Sumitomo Pharma Co., Ltd. (TYO:4506)
1,842.50
-53.00 (-2.80%)
Nov 20, 2026, 9:20 AM JST
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of 826.53 billion as of November 19, 2026. It is the 3,325th most valuable company in the world and the 230th biggest in Japan. Its market cap has decreased by 14.67% in one year.
Market Cap
826.53B
Enterprise Value
888.47B
Revenue
492.66B
Global Rank
Country Rank
#230 Japan
PE Ratio
16.72
ChartMarket Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 205.93B to 826.53B, an increase of 301.37%. That is a compound annual growth rate of 4.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 826.53B | -10.25% |
| Dec 30, 2025 | 920.92B | 311.72% |
| Dec 30, 2024 | 223.67B | 20.82% |
| Dec 29, 2023 | 185.14B | -53.35% |
| Dec 30, 2022 | 396.90B | -24.60% |
| Dec 30, 2021 | 526.41B | -13.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Takeda Pharmaceutical Company | 11.13T |
| Shionogi & | 2.75T |
| Eisai | 1.49T |
| Tsumura & Co. | 295.50B |
| Nippon Shinyaku | 231.93B |
| Sawai Group Holdings | 194.18B |
| Kissei Pharmaceutical | 175.09B |
| Towa Pharmaceutical | 165.19B |